Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
70-Gene classifier for differentiation between paclitaxel- and docetaxel-sensitive breast cancers.
Naoi Y, Tanei T, Kishi K, Tsunashima R, Tominaga N, Baba Y, Nakayama T, Shimazu K, Kim SJ, Tamaki Y, Noguchi S.
Cancer Lett. 2012 Jan 28;314(2):206-12. Epub 2011 Oct 1.
Related citations
Progesterone receptor is involved in 2,3,7,8-tetrachlorodibenzo-p-dioxin-stimulated breast cancer cells proliferation.
Chen YJ, Hung CM, Kay N, Chen CC, Kao YH, Yuan SS.
Cancer Lett. 2012 Jun 28;319(2):223-31. Epub 2012 Jan 18.
Co-targeting of the PI3K pathway improves the response of BRCA1 deficient breast cancer cells to PARP1 inhibition.
Kimbung S, Biskup E, Johansson I, Aaltonen K, Ottosson-Wadlund A, Gruvberger-Saal S, Cunliffe H, Fadeel B, Loman N, Berglund P, Hedenfalk I.
Cancer Lett. 2012 Jun 28;319(2):232-41. Epub 2012 Jan 20.
Hypoxia, stem cells and bone tumor.
Zeng W, Wan R, Zheng Y, Singh SR, Wei Y.
Cancer Lett. 2011 Dec 27;313(2):129-36. Epub 2011 Sep 29. Review.
CD49f-based selection of circulating tumor cells (CTCs) improves detection across breast cancer subtypes.
Mostert B, Kraan J, Sieuwerts AM, van der Spoel P, Bolt-de Vries J, Prager-van der Smissen WJ, Smid M, Timmermans AM, Martens JW, Gratama JW, Foekens JA, Sleijfer S.
Cancer Lett. 2012 Jun 1;319(1):49-55. Epub 2011 Dec 24.
A novel imidazopyridine analogue as a phosphatidylinositol 3-kinase inhibitor against human breast cancer.
Lee H, Li GY, Jeong Y, Jung KH, Lee JH, Ham K, Hong S, Hong SS.
Cancer Lett. 2012 May 1;318(1):68-75. Epub 2011 Dec 8.
Developmental pathways in breast cancer and breast tumor-initiating cells: therapeutic implications.
Izrailit J, Reedijk M.
Cancer Lett. 2012 Apr 28;317(2):115-26. Epub 2011 Nov 26. Review.
The Na+/H+ exchanger NHE1, but not the Na+, HCO3(-) cotransporter NBCn1, regulates motility of MCF7 breast cancer cells expressing constitutively active ErbB2.
Lauritzen G, Stock CM, Lemaire J, Lund SF, Jensen MF, Damsgaard B, Petersen KS, Wiwel M, Rønnov-Jessen L, Schwab A, Pedersen SF.
Cancer Lett. 2012 Apr 28;317(2):172-83. Epub 2011 Nov 25.
Resveratrol inhibits the epidermal growth factor-induced epithelial mesenchymal transition in MCF-7 cells.
Vergara D, Valente CM, Tinelli A, Siciliano C, Lorusso V, Acierno R, Giovinazzo G, Santino A, Storelli C, Maffia M.
Cancer Lett. 2011 Nov 1;310(1):1-8. Epub 2011 Jun 24.
DNA demethylation by 5-aza-2-deoxycytidine treatment abrogates 17 beta-estradiol-induced cell growth and restores expression of DNA repair genes in human breast cancer cells.
Singh KP, Treas J, Tyagi T, Gao W.
Cancer Lett. 2012 Mar;316(1):62-9. Epub 2011 Oct 23.
ABCB1/MDR1 contributes to the anticancer drug-resistant phenotype of IPH-926 human lobular breast cancer cells.
Krech T, Scheuerer E, Geffers R, Kreipe H, Lehmann U, Christgen M.
Cancer Lett. 2012 Feb 28;315(2):153-60. Epub 2011 Oct 12.
PPARgamma-PGC-1alpha activity is determinant of alcohol related breast cancer.
Petersen RK, Larsen SB, Jensen DM, Christensen J, Olsen A, Loft S, Nellemann C, Overvad K, Kristiansen K, Tjønneland A, Vogel U.
Cancer Lett. 2012 Feb 1;315(1):59-68. doi: 10.1016/j.canlet.2011.10.009. Epub 2011 Oct 10.
Regulation of ADP-ribosylation factor 4 expression by small leucine zipper protein and involvement in breast cancer cell migration.
Jang SY, Jang SW, Ko J.
Cancer Lett. 2012 Jan 28;314(2):185-97. Epub 2011 Sep 29.
Smad7 acts as a negative regulator of the epidermal growth factor (EGF) signaling pathway in breast cancer cells.
Kim S, Han J, Lee SK, Koo M, Cho DH, Bae SY, Choi MY, Kim JS, Kim JH, Choe JH, Yang JH, Nam SJ, Lee JE.
Cancer Lett. 2012 Jan 28;314(2):147-54. Epub 2011 Sep 29.
Calycosin promotes proliferation of estrogen receptor-positive cells via estrogen receptors and ERK1/2 activation in vitro and in vivo.
Chen J, Liu L, Hou R, Shao Z, Wu Y, Chen X, Zhou L.
Cancer Lett. 2011 Sep 28;308(2):144-51. Epub 2011 May 25.
Nitidine Chloride inhibits breast cancer cells migration and invasion by suppressing c-Src/FAK associated signaling pathway.
Pan X, Han H, Wang L, Yang L, Li R, Li Z, Liu J, Zhao Q, Qian M, Liu M, Du B.
Cancer Lett. 2011 Dec 27;313(2):181-91. Epub 2011 Sep 10.
Differential expression of microRNA expression in tamoxifen-sensitive MCF-7 versus tamoxifen-resistant LY2 human breast cancer cells.
Manavalan TT, Teng Y, Appana SN, Datta S, Kalbfleisch TS, Li Y, Klinge CM.
Cancer Lett. 2011 Dec 26;313(1):26-43. Epub 2011 Sep 10.
Inactivation of Rac1 reduces Trastuzumab resistance in PTEN deficient and insulin-like growth factor I receptor overexpressing human breast cancer SKBR3 cells.
Zhao Y, Wang Z, Jiang Y, Yang C.
Cancer Lett. 2011 Dec 26;313(1):54-63. Epub 2011 Sep 3.
Efficacy and safety of intraoperative radiotherapy in breast cancer: a systematic review.
Ruano-Ravina A, Cantero-Muñoz P, Eraso Urién A.
Cancer Lett. 2011 Dec 26;313(1):15-25. Epub 2011 Aug 31. Review.
Pegylated liposomal doxorubicin as first-line monotherapy in elderly women with locally advanced or metastatic breast cancer: novel treatment predictive factors identified.
Green H, Stål O, Bachmeier K, Bäcklund LM, Carlsson L, Hansen J, Lagerlund M, Norberg B, Franzén Å, Åleskog A, Malmström A.
Cancer Lett. 2011 Dec 27;313(2):145-53. Epub 2011 Aug 31.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on